XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.4.0.3

Auction Rate Securities | 9 Months Ended
--- | ---
Mar. 31, 2016
Text Block [Abstract] |
Auction Rate Securities | 5. Auction Rate Securities Our ARS investments, which are primarily included in non-current other assets in the condensed consolidated balance sheets, have failed to settle in auctions beginning in 2007. These investments are not liquid, and in the event we need to access these funds, we will not be able to do so without a loss of principal, unless redeemed by the issuers or a future auction on these investments is successful. During the nine months ended March 31, 2016, $0.6 million of our ARS investments were redeemed at par value. As there are currently no active markets for our various failed ARS investments, we have estimated the fair value of these investments as of March 31, 2016 using a trinomial discounted cash flow analysis. The analysis considered, among others, the following factors:
| · | the collateral underlying the security investments;
| · | the creditworthiness of the counterparty;
| · | the timing of expected future cash flows;
| · | the probability of a successful auction in a future period;
| · | the underlying structure of each investment;
| · | the present value of future principal and interest payments discounted at rates considered to reflect current market conditions;
| · | a consideration of the probabilities of default, a successful future auction, or redemption at par for each period; and
| · | estimates of the recovery rates in the event of default for each investment.
When possible, our failed ARS investments were compared to other observable market data or securities with similar characteristics. Our estimate of the fair value of our ARS investments could fluctuate from period to period depending on future market conditions. We have ARS investments with a fair value of $12.6 million maturing in fiscal year 2018 and $1.5 million fair value with no maturity date. As of March 31, 2016 all of our ARS investments are below investment grade. The various types of ARS investments we held as of March 31, 2016, including the original cost basis, other-than-temporary impairment included in retained earnings, new cost basis, unrealized gain, and fair value, consisted of the following (in millions):
|  | Original Cost Basis |  |  | Other-than- temporary Impairment in Retained Earnings |  |  | New Cost Basis |  |  | Unrealized Gain |  |  | Fair Value |
Credit linked notes |  | $ | 13.5 |  |  | $ | (4.7 | ) | (1) | $ | 8.8 |  |  | $ | 3.8 |  |  | $ | 12.6 |
Preferred stock |  |  | 5.0 |  |  |  | (5.0 | ) |  |  | - |  |  |  | 1.5 |  |  |  | 1.5 |
Total ARS |  | $ | 18.5 |  |  | $ | (9.7 | ) |  | $ | 8.8 |  |  | $ | 5.3 |  |  | $ | 14.1 |
(1) | Other-than-temporary impairment in retained earnings is partially offset by cumulative accretion of $4.1 million on non-current investments. Accretion is reclassified from accumulated other comprehensive income and recorded in the condensed consolidated statements of income as non-cash interest income.
The various types of ARS investments we held as of June 30, 2015, including the original cost basis, other-than-temporary impairment included in retained earnings, new cost basis, unrealized gain, and fair value, consisted of the following (in millions):
|  | Original Cost Basis |  |  | Other-than- temporary Impairment in Retained Earnings |  |  | New Cost Basis |  |  | Unrealized Gain |  |  | Fair Value |
Credit linked notes |  | $ | 13.5 |  |  | $ | (6.1 | ) | (1) | $ | 7.4 |  |  | $ | 5.0 |  |  | $ | 12.4 |
Preferred stock |  |  | 5.0 |  |  |  | (5.0 | ) |  |  | - |  |  |  | 2.8 |  |  |  | 2.8 |
Municipals |  |  | 0.6 |  |  |  | (0.1 | ) |  |  | 0.5 |  |  |  | 0.1 |  |  |  | 0.6 |
Total ARS |  | $ | 19.1 |  |  | $ | (11.2 | ) |  | $ | 7.9 |  |  | $ | 7.9 |  |  | $ | 15.8 |
(1) | Other-than-temporary impairment in retained earnings is partially offset by cumulative accretion of $2.7 million on non-current investments. Accretion is reclassified from accumulated other comprehensive income and recorded in the condensed consolidated statements of income as non-cash interest income.
All of our ARS investments are accounted for as non-current as the maturity dates are more than 12 months from the balance sheet date. We do not intend to sell the ARS investments before the recovery of the amortized cost basis and it is not more likely than not that we will be required to sell the investments before the recovery of the amortized cost basis.

X
- Definition The entire disclosure for auction rate securities. + References No definition available. + Details
Name: | syna_AuctionRateSecuritiesTextBlock
Namespace Prefix: | syna_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration